ArticleInflammatory bowel diseases2022

Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study.

Pepijn W A Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.